Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0000904454-04-000374
Filing Date
2004-05-28
Accepted
2004-05-28 14:56:57
Documents
1
Period of Report
2004-04-21

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4/A  
1 PRIMARY DOCUMENT edgar.xml 4/A 9864
  Complete submission text file 0000904454-04-000374.txt   11816
Mailing Address
Business Address ONE JOHNSON & JOHNSON PLZ NEW BRUNSWICK NJ 08933 7325242454
JOHNSON & JOHNSON (Reporting) CIK: 0000200406 (see all company filings)

State of Incorp.: NJ | Fiscal Year End: 0103
Type: 4/A | Act: 34 | File No.: 000-50677 | Film No.: 04838195
SIC: 2834 Pharmaceutical Preparations

Mailing Address
Business Address
JOHNSON & JOHNSON DEVELOPMENT CORP ET AL (Reporting) CIK: 0000924020 (see all company filings)

Type: 4/A | Act: 34 | File No.: 000-50677 | Film No.: 04838194

Mailing Address
Business Address 3401 MASONS MILL RD SUITE 100 HUNTINGTON VALLEY PA 19006 215 830 0777 X121
IMMUNICON CORP (Issuer) CIK: 0001083132 (see all company filings)

SIC: 3826 Laboratory Analytical Instruments